(Q34434119)

2 August 2017

1 reference

title

Early intervention in psychotic relapse (English)

1 reference

ORCID Public Data File 2021

2 August 2017

1 reference

1 reference

author name string

Birchwood M

series ordinal

1

1 reference

2 August 2017

Spencer E

series ordinal

2

1 reference

2 August 2017

publication date

1 November 2001

1 reference

Clinical Psychology Review

2 August 2017

published in

1 reference

2 August 2017

volume

21

1 reference

2 August 2017

issue

8

1 reference

2 August 2017

page(s)

1211-1226

1 reference

Early Intervention in Psychotic Relapse: Cognitive Approaches to Detection and Management

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2801%2900105-2

7 January 2021

Cognitive approach to depression and suicidal thinking in psychosis. 1. Ontogeny of post-psychotic depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2801%2900105-2

7 January 2021

Cognitive approach to depression and suicidal thinking in psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2801%2900105-2

7 January 2021

The power and omnipotence of voices: subordination and entrapment by voices and significant others

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2801%2900105-2

7 January 2021

Predicting relapse in schizophrenia: the development and implementation of an early signs monitoring system using patients and families as observers, a preliminary investigation*

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2801%2900105-2

7 January 2021

Depression, demoralization and control over psychotic illness: a comparison of depressed and non-depressed patients with a chronic psychosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2801%2900105-2

7 January 2021

Early intervention in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2801%2900105-2

7 January 2021

Self-control in psychotic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2801%2900105-2

7 January 2021

Expressed emotion and psychiatric relapse: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2801%2900105-2

7 January 2021

Continuous versus targeted medication in schizophrenic outpatients: outcome results

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2801%2900105-2

7 January 2021

The omnipotence of voices. A cognitive approach to auditory hallucinations

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2801%2900105-2

7 January 2021

Suicide among schizophrenics: a comparison of attempters and completed suicides

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2801%2900105-2

7 January 2021

Cognitive Therapy and Recovery from Acute Psychosis: a Controlled Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2801%2900105-2

7 January 2021

Cognitive therapy and recovery from acute psychosis: A controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2801%2900105-2

7 January 2021

Subclinical symptoms in mood disorders: pathophysiological and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2801%2900105-2

7 January 2021

Prodromal states in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2801%2900105-2

7 January 2021

The ABC Schizophrenia Study: a preliminary overview of the results.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2801%2900105-2

7 January 2021

Predicting the long-term outcome of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2801%2900105-2

7 January 2021

Early insight and the management of schizophrenic decompensation.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2801%2900105-2

7 January 2021

Relapse in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2801%2900105-2

7 January 2021

Prodromal symptoms and relapse prevention in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2801%2900105-2

7 January 2021

A program for relapse prevention in schizophrenia: a controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2801%2900105-2

7 January 2021

A one year prospective study of the effect of life events and medication in the aetiology of schizophrenic relapse

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2801%2900105-2

7 January 2021

People at risk of schizophrenia. Sample characteristics of the first 100 cases in the Edinburgh High-Risk Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2801%2900105-2

7 January 2021

Three-year trials of personal therapy among schizophrenic patients living with or independent of family, I: Description of study and effects on relapse rates

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2801%2900105-2

7 January 2021

Three-year trials of personal therapy among schizophrenic patients living with or independent of family, II: Effects on adjustment of patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2801%2900105-2

7 January 2021

Trial of brief intermittent neuroleptic prophylaxis for selected schizophrenic outpatients: clinical and social outcome at two years

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2801%2900105-2

7 January 2021

Early signs of psychotic relapse in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2801%2900105-2

7 January 2021

What is relapse in schizophrenia?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2801%2900105-2

7 January 2021

Prodromal symptoms in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2801%2900105-2

7 January 2021

Costs and benefits of two doses of fluphenazine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2801%2900105-2

7 January 2021

Low- and conventional-dose maintenance therapy with fluphenazine decanoate. Two-year outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2801%2900105-2

7 January 2021

Fluphenazine vs placebo supplementation for prodromal signs of relapse in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2801%2900105-2

7 January 2021

The dimensional structure of first episode psychosis: an exploratory factor analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2801%2900105-2

7 January 2021

An assessment of the educational needs of chronic psychiatric patients and their relatives.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2801%2900105-2

7 January 2021

A heuristic vulnerability/stress model of schizophrenic episodes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2801%2900105-2

7 January 2021

Prodromal symptoms of relapse in schizophrenia: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2801%2900105-2

7 January 2021

The natural history of schizophrenia: a five-year follow-up study of outcome and prediction in a representative sample of schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2801%2900105-2

7 January 2021

Two-year follow-up of cognitive-behavioral therapy and supportive counseling in the treatment of persistent symptoms in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2801%2900105-2

7 January 2021

Natural course of schizophrenic disorders: a 15-year followup of a Dutch incidence cohort.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2801%2900105-2

7 January 2021

Monitoring and care of young people at incipient risk of psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2801%2900105-2

7 January 2021

Prodromal signs and symptoms of schizophrenic relapse.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2801%2900105-2

7 January 2021

10.1016/S0272-7358(01)00105-2

Identifiers

DOI

1 reference

2 August 2017

1 reference